{
  "study_id": "ACTRN12608000588392",
  "study_title": "A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial",
  "table_name": "Table 1",
  "table_title": "Baseline characteristics",
  "footnotes": [],
  "groups": [
    {
      "name": "Chemotherapy + nitroglycerin",
      "n": 187,
      "type": "intervention"
    },
    {
      "name": "Chemotherapy alone",
      "n": 185,
      "type": "control"
    }
  ],
  "characteristics": [
    {
      "original_label": "Age (years)",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "<50",
      "standardized_name": "Age <50 years",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 11.0,
          "percentage": 6.0,
          "raw_string": "11 (6)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 8.0,
          "percentage": 4.0,
          "raw_string": "8 (4)"
        }
      ]
    },
    {
      "original_label": "50-59",
      "standardized_name": "Age 50-59 years",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 49.0,
          "percentage": 26.0,
          "raw_string": "49 (26)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 43.0,
          "percentage": 23.0,
          "raw_string": "43 (23)"
        }
      ]
    },
    {
      "original_label": "60-69",
      "standardized_name": "Age 60-69 years",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 77.0,
          "percentage": 41.0,
          "raw_string": "77 (41)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 80.0,
          "percentage": 43.0,
          "raw_string": "80 (43)"
        }
      ]
    },
    {
      "original_label": "70-79",
      "standardized_name": "Age 70-79 years",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 48.0,
          "percentage": 26.0,
          "raw_string": "48 (26)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 51.0,
          "percentage": 28.0,
          "raw_string": "51 (28)"
        }
      ]
    },
    {
      "original_label": "â‰¥80",
      "standardized_name": "Age >= 80 years",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.0,
          "raw_string": "2 (1)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 2.0,
          "raw_string": "3 (2)"
        }
      ]
    },
    {
      "original_label": "Gender",
      "standardized_name": "Sex",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Female",
      "standardized_name": "Female",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 73.0,
          "percentage": 39.0,
          "raw_string": "73 (39)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 74.0,
          "percentage": 40.0,
          "raw_string": "74 (40)"
        }
      ]
    },
    {
      "original_label": "Male",
      "standardized_name": "Male",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Sex",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 114.0,
          "percentage": 61.0,
          "raw_string": "114 (61)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 111.0,
          "percentage": 60.0,
          "raw_string": "111 (60)"
        }
      ]
    },
    {
      "original_label": "ECOG performance status",
      "standardized_name": "ECOG Performance Status",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "0",
      "standardized_name": "ECOG Performance Status 0",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG Performance Status",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 60.0,
          "percentage": 32.0,
          "raw_string": "60 (32)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 65.0,
          "percentage": 35.0,
          "raw_string": "65 (35)"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "ECOG Performance Status 1",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG Performance Status",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 114.0,
          "percentage": 61.0,
          "raw_string": "114 (61)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 106.0,
          "percentage": 57.0,
          "raw_string": "106 (57)"
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "ECOG Performance Status 2",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "ECOG Performance Status",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 13.0,
          "percentage": 7.0,
          "raw_string": "13 (7)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 14.0,
          "percentage": 8.0,
          "raw_string": "14 (8)"
        }
      ]
    },
    {
      "original_label": "Histology",
      "standardized_name": "Histology",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Adenocarcinoma",
      "standardized_name": "Adenocarcinoma",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 124.0,
          "percentage": 66.0,
          "raw_string": "124 (66)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 122.0,
          "percentage": 66.0,
          "raw_string": "122 (66)"
        }
      ]
    },
    {
      "original_label": "Squamous",
      "standardized_name": "Squamous Cell Carcinoma",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 41.0,
          "percentage": 22.0,
          "raw_string": "41 (22)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 39.0,
          "percentage": 21.0,
          "raw_string": "39 (21)"
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "Other Histology",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histology",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 22.0,
          "percentage": 12.0,
          "raw_string": "22 (12)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 24.0,
          "percentage": 13.0,
          "raw_string": "24 (13)"
        }
      ]
    },
    {
      "original_label": "Stage at diagnosis (AJCC 2002)",
      "standardized_name": "AJCC Stage",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "III",
      "standardized_name": "Stage III",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "AJCC Stage",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 18.0,
          "percentage": 10.0,
          "raw_string": "18 (10)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 19.0,
          "percentage": 10.0,
          "raw_string": "19 (10)"
        }
      ]
    },
    {
      "original_label": "IV",
      "standardized_name": "Stage IV",
      "category": "Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "AJCC Stage",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 169.0,
          "percentage": 90.0,
          "raw_string": "169 (90)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 166.0,
          "percentage": 90.0,
          "raw_string": "166 (90)"
        }
      ]
    },
    {
      "original_label": "Smoker",
      "standardized_name": "Smoking Status",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Current",
      "standardized_name": "Current Smoker",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking Status",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 20.0,
          "raw_string": "36 (20)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 35.0,
          "percentage": 19.0,
          "raw_string": "35 (19)"
        }
      ]
    },
    {
      "original_label": "Within 15 years",
      "standardized_name": "Former Smoker (Quit within 15 years)",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking Status",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 90.0,
          "percentage": 51.0,
          "raw_string": "90 (51)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 92.0,
          "percentage": 52.0,
          "raw_string": "92 (52)"
        }
      ]
    },
    {
      "original_label": ">15 years or never smoker",
      "standardized_name": "Former Smoker (Quit >15 years) or Never Smoker",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Smoking Status",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 51.0,
          "percentage": 29.0,
          "raw_string": "51 (29)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 50.0,
          "percentage": 28.0,
          "raw_string": "50 (28)"
        }
      ]
    },
    {
      "original_label": "Prior radiotherapy",
      "standardized_name": "Prior Radiotherapy",
      "category": "Treatment History",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Yes",
      "standardized_name": "Prior Radiotherapy: Yes",
      "category": "Treatment History",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Prior Radiotherapy",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 49.0,
          "percentage": 26.0,
          "raw_string": "49 (26)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 55.0,
          "percentage": 30.0,
          "raw_string": "55 (30)"
        }
      ]
    },
    {
      "original_label": "Planned chemotherapy",
      "standardized_name": "Planned Chemotherapy Regimen",
      "category": "Treatment Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Carboplatin and gemcitabine",
      "standardized_name": "Carboplatin and Gemcitabine",
      "category": "Treatment Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Planned Chemotherapy Regimen",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 148.0,
          "percentage": 79.0,
          "raw_string": "148 (79)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 146.0,
          "percentage": 79.0,
          "raw_string": "146 (79)"
        }
      ]
    },
    {
      "original_label": "Carboplatin and paclitaxel",
      "standardized_name": "Carboplatin and Paclitaxel",
      "category": "Treatment Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Planned Chemotherapy Regimen",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 35.0,
          "percentage": 18.0,
          "raw_string": "35 (18)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 34.0,
          "percentage": 18.0,
          "raw_string": "34 (18)"
        }
      ]
    },
    {
      "original_label": "Cisplatin and vinorelbine",
      "standardized_name": "Cisplatin and Vinorelbine",
      "category": "Treatment Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Planned Chemotherapy Regimen",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 2.0,
          "raw_string": "3 (2)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 2.0,
          "raw_string": "3 (2)"
        }
      ]
    },
    {
      "original_label": "(Cisplatin or carboplatin) and pemetrexed",
      "standardized_name": "(Cisplatin or Carboplatin) and Pemetrexed",
      "category": "Treatment Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Planned Chemotherapy Regimen",
      "group_data": [
        {
          "group_name": "Chemotherapy + nitroglycerin",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 1.0,
          "raw_string": "1 (1)"
        },
        {
          "group_name": "Chemotherapy alone",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 1.0,
          "raw_string": "2 (1)"
        }
      ]
    }
  ]
}